TP53 and breast carcinoma: Similarly, several genomic features (BRCA1 inactivation, RB1 loss and cyclin E1 amplification, high expression of AKT3, MYC amplification and high expression; and a high frequency of TP53 mutations) were found to be similar between Basal-like breast cancer and high-grade serous ovarian cancer53.